arsenic trioxide has been researched along with arsthinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajana, I; Astier, A; Gibaud, S | 1 |
| Aniceto, N; Astier, A; Becherirat, S; Gibaud, S; Lanhers, MC; Loboda, C; Socha, M; Yemloul, M | 1 |
2 other study(ies) available for arsenic trioxide and arsthinol
| Article | Year |
|---|---|
Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow; Brain; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Melarsoprol; Mice; Mice, Inbred Strains; Nanotechnology; Oxides; Suspensions | 2009 |
The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; beta-Cyclodextrins; Brain Neoplasms; Cell Line, Tumor; Excipients; Female; Glioma; Humans; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Melarsoprol; Mice; Mice, Nude; Oxides; Xenograft Model Antitumor Assays | 2013 |